NCT00006108View on ClinicalTrials.gov

Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 1999

Primary Completion Date

September 30, 2001

Study Completion Date

July 31, 2002

Conditions
Breast Cancer
Interventions
BIOLOGICAL

trastuzumab

DRUG

capecitabine

DRUG

paclitaxel

Trial Locations (1)

27599-7295

Lineberger Comprehensive Cancer Center, UNC, Chapel Hill

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

UNC Lineberger Comprehensive Cancer Center

OTHER

NCT00006108 - Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter